These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1987229)

  • 1. Clinical and angiographic determinants of primary coronary angioplasty success. M-HEART Investigators.
    Savage MP; Goldberg S; Hirshfeld JW; Bass TA; MacDonald RG; Margolis JR; Taussig AS; Vetrovec G; Whitworth HB; Zalewski A
    J Am Coll Cardiol; 1991 Jan; 17(1):22-8. PubMed ID: 1987229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.
    Hirshfeld JW; Schwartz JS; Jugo R; MacDonald RG; Goldberg S; Savage MP; Bass TA; Vetrovec G; Cowley M; Taussig AS
    J Am Coll Cardiol; 1991 Sep; 18(3):647-56. PubMed ID: 1869725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.
    Ellis SG; Popma JJ; Buchbinder M; Franco I; Leon MB; Kent KM; Pichard AD; Satler LF; Topol EJ; Whitlow PL
    Circulation; 1994 Feb; 89(2):882-92. PubMed ID: 8313578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
    Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
    Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
    Ellis SG; Vandormael MG; Cowley MJ; DiSciascio G; Deligonul U; Topol EJ; Bulle TM
    Circulation; 1990 Oct; 82(4):1193-202. PubMed ID: 2401060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional atherectomy versus balloon angioplasty for coronary ostial and nonostial left anterior descending coronary artery lesions: results from a randomized multicenter trial. The CAVEAT-I investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Boehrer JD; Ellis SG; Pieper K; Holmes DR; Keeler GP; Debowey D; Chapekis AT; Leya F; Mooney MR; Gottlieb RS
    J Am Coll Cardiol; 1995 May; 25(6):1380-6. PubMed ID: 7722137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
    Renkin J; Melin J; Robert A; Richelle F; Bachy JL; Col J; Detry JM; Wijns W
    J Am Coll Cardiol; 1990 Nov; 16(6):1333-40. PubMed ID: 2229783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
    Bourassa MG; Lespérance J; Eastwood C; Schwartz L; Côté G; Kazim F; Hudon G
    J Am Coll Cardiol; 1991 Aug; 18(2):368-76. PubMed ID: 1856404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.
    Robertson T; Kennard ED; Mehta S; Popma JJ; Carrozza JP; King SB; Holmes DR; Cowley MJ; Hornung CA; Kent KM; Roubin GS; Litvack F; Moses JW; Safian R; Desvigne-Nickens P; Detre KM
    Am J Cardiol; 1997 Nov; 80(10A):26K-39K. PubMed ID: 9409690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left anterior descending coronary artery stenosis in 351 patients.
    Ten Berg JM; Gin MT; Ernst SM; Kelder JC; Suttorp MJ; Mast EG; Bal E; Plokker HW
    J Am Coll Cardiol; 1996 Jul; 28(1):82-8. PubMed ID: 8752798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty in heart transplant recipients: a quantitative angiographic long-term follow-up study.
    Christensen BV; Meyer SM; Iacarella CL; Kubo SH; Wilson RF
    J Heart Lung Transplant; 1994; 13(2):212-20. PubMed ID: 8031802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry.
    Bittl JA; Sanborn TA; Tcheng JE; Siegel RM; Ellis SG
    Am J Cardiol; 1992 Dec; 70(20):1533-9. PubMed ID: 1466319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.